0000899243-17-015331.txt : 20170605 0000899243-17-015331.hdr.sgml : 20170605 20170605164004 ACCESSION NUMBER: 0000899243-17-015331 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170601 FILED AS OF DATE: 20170605 DATE AS OF CHANGE: 20170605 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CytoDyn Inc. CENTRAL INDEX KEY: 0001175680 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 753056237 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 BUSINESS ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 BUSINESS PHONE: 360-980-8524 MAIL ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 FORMER COMPANY: FORMER CONFORMED NAME: CYTODYN INC DATE OF NAME CHANGE: 20031114 FORMER COMPANY: FORMER CONFORMED NAME: REXRAY CORP DATE OF NAME CHANGE: 20020617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pourhassan Nader CENTRAL INDEX KEY: 0001532878 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-49908 FILM NUMBER: 17891711 MAIL ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-06-01 0 0001175680 CytoDyn Inc. CYDY 0001532878 Pourhassan Nader 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 1 1 0 0 President and CEO Stock Options (right to buy) 0.57 2017-06-01 4 A 0 300000 0.00 A 2027-06-01 Common Stock 300000 300000 D Subject to stockholder approval, at the next annual meeting, of the increase in the number of shares of common stock authorized for issuance under the CytoDyn Inc. 2012 Equity Incentive Plan, as amended, the options will vest in three equal annual installments commencing on June 1, 2018. /s/ Michael D. Mulholland, as attorney-in-fact 2017-06-05